Search research articles
Contact Us
Filters
Showing results (431-440 of 594) with videos related to
Page
of 60
Sort By:
Cancer Cell
|
November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li, Yi Xiao, Qin Li, et al.
The Oncologist
|
February 28, 2026
Phase I Trial of Binimetinib Plus Hydroxychloroquine in Patients with Previously Treated Metastatic Pancreatic Cancer
S Daniel Haldar, Fen Saj, So Jung Hong, et al.
Seminars in Radiation Oncology
|
May 9, 2018
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation
Steven J Frank, Pierre Blanchard, J Jack Lee, et al.
JAMA Network Open
|
May 17, 2023
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials
Marcus A Florez, Joseph Abi Jaoude, Roshal R Patel, et al.
Cancer Research
|
May 20, 2016
Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study
Jennifer J Wheler, Filip Janku, Aung Naing, et al.
Clinical Lung Cancer
|
June 11, 2014
Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion
Erminia Massarelli, Amir Onn, Edith M Marom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study
Anita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Journal of the National Cancer Institute
|
April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients
Fadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2006
Fenretinide activity in retinoid-resistant oral leukoplakia
Scott M Lippman, J Jack Lee, Jack W Martin, et al.
JAMA Network Open
|
June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
Yufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Page
of 60
Search research articles
Search
Showing results (431-440 of 594) with videos related to
Sort By:
Page
of 60
Cancer Cell
|
November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li, Yi Xiao, Qin Li, et al.
The Oncologist
|
February 28, 2026
Phase I Trial of Binimetinib Plus Hydroxychloroquine in Patients with Previously Treated Metastatic Pancreatic Cancer
S Daniel Haldar, Fen Saj, So Jung Hong, et al.
Seminars in Radiation Oncology
|
May 9, 2018
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation
Steven J Frank, Pierre Blanchard, J Jack Lee, et al.
JAMA Network Open
|
May 17, 2023
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials
Marcus A Florez, Joseph Abi Jaoude, Roshal R Patel, et al.
Cancer Research
|
May 20, 2016
Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study
Jennifer J Wheler, Filip Janku, Aung Naing, et al.
Clinical Lung Cancer
|
June 11, 2014
Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion
Erminia Massarelli, Amir Onn, Edith M Marom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study
Anita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Journal of the National Cancer Institute
|
April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients
Fadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2006
Fenretinide activity in retinoid-resistant oral leukoplakia
Scott M Lippman, J Jack Lee, Jack W Martin, et al.
JAMA Network Open
|
June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
Yufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Page
of 60